213 related articles for article (PubMed ID: 21174065)
1. Inhibin-α subunit expression in uterine endometrioid adenocarcinomas and endometrial cancer cell lines: a potential prognostic factor.
Mylonas I
Int J Mol Med; 2011 Mar; 27(3):309-18. PubMed ID: 21174065
[TBL] [Abstract][Full Text] [Related]
2. Inhibin-βA subunit immunolabeling as a prognostic factor in endometrioid adenocarcinomas: a matter of evaluation?
Mylonas I
Arch Gynecol Obstet; 2011 Aug; 284(2):467-76. PubMed ID: 20865419
[TBL] [Abstract][Full Text] [Related]
3. Inhibin-alpha, -betaA and -betaB subunits in uterine non-endometrioid carcinomas: prognostic significance and clinical implications.
Mylonas I
Eur J Cancer; 2010 Sep; 46(13):2485-93. PubMed ID: 20599374
[TBL] [Abstract][Full Text] [Related]
4. Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers.
Worbs S; Shabani N; Mayr D; Gingelmaier A; Makrigiannakis A; Kuhn C; Jeschke U; Kupka MS; Friese K; Mylonas I
Oncol Rep; 2007 Jan; 17(1):97-104. PubMed ID: 17143484
[TBL] [Abstract][Full Text] [Related]
5. Inhibin/activin-betaC subunit does not represent a prognostic parameter in human endometrial cancer.
Käufl SD; Kuhn C; Kunze S; Shabani N; Brüning A; Friese K; Mylonas I
Arch Gynecol Obstet; 2011 Jul; 284(1):199-207. PubMed ID: 20683603
[TBL] [Abstract][Full Text] [Related]
6. Inhibin beta B: a useful tumor marker in uterine endometrioid adenocarcinomas?
Mylonas I
Histol Histopathol; 2011 Nov; 26(11):1415-22. PubMed ID: 21938679
[TBL] [Abstract][Full Text] [Related]
7. The immunohistochemical expression of the inhibin/activin subunits is up-regulated by interferon-beta1a in Ishikawa cell line.
Hoeing A; Kuhn C; Shabani N; Schulze S; Gingelmaier A; Dian D; Jeschke U; Friese K; Mylonas I
Anticancer Res; 2007; 27(4A):2005-10. PubMed ID: 17649813
[TBL] [Abstract][Full Text] [Related]
8. Inhibin/activin-betaC and -betaE subunits in the Ishikawa human endometrial adenocarcinoma cell line.
Kimmich T; Brüning A; Käufl SD; Makovitzky J; Kuhn C; Jeschke U; Friese K; Mylonas I
Arch Gynecol Obstet; 2010 Aug; 282(2):185-91. PubMed ID: 20012305
[TBL] [Abstract][Full Text] [Related]
9. Inhibin/activin betaE-subunit in uterine endometrioid adenocarcinoma and endometrial cancer cell lines: from immunohistochemistry to clinical testing?
Mylonas I; Matsingou C; Käufl SD; Brüning A
Gynecol Oncol; 2011 Jul; 122(1):132-40. PubMed ID: 21507472
[TBL] [Abstract][Full Text] [Related]
10. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H
Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875
[TBL] [Abstract][Full Text] [Related]
11. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
[TBL] [Abstract][Full Text] [Related]
12. Expression of the inhibin-alpha subunit in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis.
Mylonas I; Makovitzky J; Richter DU; Jeschke U; Briese V; Friese K
Gynecol Oncol; 2004 Apr; 93(1):92-7. PubMed ID: 15047219
[TBL] [Abstract][Full Text] [Related]
13. Expression of HPV, steroid receptors (ERalpha, ERbeta, PR-A and PR-B) and inhibin/activin subunits (alpha, betaA and betaB) in adenosquamous endometrial carcinoma.
Gingelmaier A; Gutsche S; Mylonas I; Shabani N; Kuhn C; Kunze S; Jeschke U; Friese K
Anticancer Res; 2007; 27(4A):2011-7. PubMed ID: 17649814
[TBL] [Abstract][Full Text] [Related]
14. Mucin 1, Thomsen-Friedenreich expression and galectin-1 binding in endometrioid adenocarcinoma: an immunohistochemical analysis.
Mylonas I; Mayr D; Walzel H; Shabani N; Dian D; Kuhn C; Kunze S; Jeschke U; Friese K
Anticancer Res; 2007; 27(4A):1975-80. PubMed ID: 17649808
[TBL] [Abstract][Full Text] [Related]
15. Immunolabelling of the inhibin/activin-βC subunit in normal and malignant human uterine cervical tissue and cervical cancer cell lines.
Blankenstein T; Jückstock J; Shabani N; Kunze S; Brüning A; Bergauer F; Mylonas I
Oncol Rep; 2011 Jan; 25(1):147-52. PubMed ID: 21109970
[TBL] [Abstract][Full Text] [Related]
16. Inhibin/activin-betaC subunit in human endometrial adenocarcinomas and HEC-1a adenocarcinoma cell line.
Käufl SD; Makovitzky J; Kuhn C; Kunze S; Jeschke U; Mylonas I
In Vivo; 2010; 24(5):695-8. PubMed ID: 20952735
[TBL] [Abstract][Full Text] [Related]
17. Inhibin/activin subunits beta-A (-betaA) and beta-B (-betaB) are differentially localised in normal, hyperplastic and malignant human endometrial tissue.
Mylonas I; Makovitzky J; Hoeing A; Richter DU; Vogl J; Schulze S; Jeschke U; Briese V; Friese K
Acta Histochem; 2006; 108(1):1-11. PubMed ID: 16423381
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer.
Nakamura M; Kyo S; Zhang B; Zhang X; Mizumoto Y; Takakura M; Maida Y; Mori N; Hashimoto M; Ohno S; Inoue M
Hum Pathol; 2010 Nov; 41(11):1516-29. PubMed ID: 20800872
[TBL] [Abstract][Full Text] [Related]
19. Sertoliform endometrioid carcinoma of the endometrium with dual immunophenotypes for epithelial membrane antigen and inhibin alpha: case report and literature review.
Liang SX; Patel K; Pearl M; Liu J; Zheng W; Tornos C
Int J Gynecol Pathol; 2007 Jul; 26(3):291-7. PubMed ID: 17581414
[TBL] [Abstract][Full Text] [Related]
20. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
Schlosshauer PW; Ellenson LH; Soslow RA
Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
